What is Immunome's net margin?

Immunome (IMNM) reported net margin of -5,593.8% in Q1 2026.

How has Immunome's net margin changed year-over-year?

Immunome's net margin decreased by 198.3% year-over-year, from -1,875.2% to -5,593.8%.

What is the long-term trend for Immunome's net margin?

Over 2 years (2023 to 2025), Immunome's net margin has grown at a 100.4% compound annual growth rate (CAGR), from -761.9% to -3,060%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Immunome IMNM Net margin

Net margin at other companies

PfizerPFE

15.7%—

Arcus BiosciencesRCUS

-156.4%-47.5pp

Nuvation BioNUVB

-102.1%-50.6pp

IDEAYA Biosciences, Inc.IDYA

-3,921.1%-4,562pp

ImmunityBio, Inc.IBRX

-606.2%-212pp

Summit TherapeuticsSMMT

-271,685%-275,966pp

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Calculated from Immunome’s reported figures.

net income/total revenue=-5,593.8%

Based on trailing twelve months.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's net margin?: Immunome (IMNM) reported net margin of -5,593.8% in Q1 2026.
How has Immunome's net margin changed year-over-year?: Immunome's net margin decreased by 198.3% year-over-year, from -1,875.2% to -5,593.8%.
What is the long-term trend for Immunome's net margin?: Over 2 years (2023 to 2025), Immunome's net margin has grown at a 100.4% compound annual growth rate (CAGR), from -761.9% to -3,060%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.